Cash Flow Statement
Growth Metrics

Biolife Solutions (BLFS) Non Operating Investment Income (2020 - 2024)

Biolife Solutions (BLFS) has disclosed Non Operating Investment Income for 6 consecutive years, with -$4.1 million as the latest value for Q2 2024.

  • Quarterly Non Operating Investment Income changed N/A to -$4.1 million in Q2 2024 from the year-ago period, while the trailing twelve-month figure was -$4.1 million through Jun 2025, changed 0.0% year-over-year, with the annual reading at -$4.1 million for FY2024, N/A changed from the prior year.
  • Non Operating Investment Income for Q2 2024 was -$4.1 million at Biolife Solutions, down from -$411000.0 in the prior quarter.
  • The five-year high for Non Operating Investment Income was $1.1 million in Q3 2020, with the low at -$4.1 million in Q2 2024.
  • Average Non Operating Investment Income over 4 years is -$442166.7, with a median of $12500.0 recorded in 2020.
  • Peak annual rise in Non Operating Investment Income hit 123.37% in 2023, while the deepest fall reached 123.37% in 2023.
  • Over 4 years, Non Operating Investment Income stood at $209000.0 in 2020, then soared by 233.49% to $697000.0 in 2022, then crashed by 158.97% to -$411000.0 in 2023, then tumbled by 891.24% to -$4.1 million in 2024.
  • According to Business Quant data, Non Operating Investment Income over the past three periods came in at -$4.1 million, -$411000.0, and $697000.0 for Q2 2024, Q1 2023, and Q3 2022 respectively.